HLA-Typed Primary Cells: The advantages of working with HLA in drug development research

For those working in drug development, human leukocyte antigens or HLA are a key element to keep in mind as an essential regulator of the immune system. Watch our latest explainer video to understand the benefits of working with HLA in your pre-clinical research.


By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Tell us your HLA donor requirements

Please give us your contact details. One of our scientific specialists will get in touch to handle your request.

Contact us

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Austria
    2. Belgium
    3. Bulgaria
    4. Croatia
    5. Czech Republic
    6. Denmark
    7. Finland
    8. France
    9. Germany
    10. Greece
    11. Hungary
    12. Ireland
    13. Italy
    14. Luxembourg
    15. Monaco
    16. Netherlands
    17. Norway
    18. Poland
    19. Portugal
    20. Romania
    21. Slovakia
    22. Slovenia
    23. Spain
    24. Sweden
    25. Switzerland
    26. United Kingdom
  3. Asia
    1. India
    2. Israel
    3. Japan
    4. Malaysia
    5. Singapore
    6. South Korea
    7. Taiwan
    8. Thailand
Scroll to top